Tumor cell DNA and proliferative machinery

Tumor cell DNA and proliferative machinery is a composite therapeutic target encompassing the genetic material and the biochemical apparatus required for cellular replication and division. This target is the primary focus of traditional cytotoxic chemotherapy, which aims to exploit the rapid growth characteristics of malignant cells [National Cancer Institute (NCI), 2023]. The machinery includes DNA itself, which can be damaged by alkylating agents, and various enzymes like topoisomerases and polymerases that facilitate DNA synthesis and structural maintenance [StatPearls, 2023]. Additionally, the mitotic spindle, composed of tubulin subunits, is a critical component of this machinery targeted by vinca alkaloids and taxanes to prevent chromosome separation [Nature Reviews Cancer, 2021]. By disrupting these essential processes, drugs induce cell cycle arrest and apoptosis in cancer cells. However, because these targets are also present in normal proliferating cells, treatment often results in significant toxicities, including bone marrow suppression and hair loss [PubMed, PMC7120411]. This target remains a cornerstone of oncology, often used in combination with more specific targeted therapies.

Other names

Cancer cell DNAReplication and mitotic machineryCell cycle apparatusGenomic DNA and associated enzymes

Inhibition of DNA replication and cell division through DNA adduct formation, antimetabolite-mediated depletion of nucleotide pools, topoisomerase-mediated DNA strand breaks, or microtubule-mediated mitotic arrest [StatPearls, 2023; NCI, 2023].